TH168784A - - Google Patents

Info

Publication number
TH168784A
TH168784A TH1601004991A TH1601004991A TH168784A TH 168784 A TH168784 A TH 168784A TH 1601004991 A TH1601004991 A TH 1601004991A TH 1601004991 A TH1601004991 A TH 1601004991A TH 168784 A TH168784 A TH 168784A
Authority
TH
Thailand
Prior art keywords
pharmaceutical
antigen
pharmaceutical components
antibody
revealed
Prior art date
Application number
TH1601004991A
Other languages
English (en)
Thai (th)
Original Assignee
นางดารานีย์ วัจนะวุฒิวงค์ นางสาวสนธยา สังขพงศ์ นางสาวสุคนธ์ทิพย์ จิตมงคลทอง
Filing date
Publication date
Application filed by นางดารานีย์ วัจนะวุฒิวงค์ นางสาวสนธยา สังขพงศ์ นางสาวสุคนธ์ทิพย์ จิตมงคลทอง filed Critical นางดารานีย์ วัจนะวุฒิวงค์ นางสาวสนธยา สังขพงศ์ นางสาวสุคนธ์ทิพย์ จิตมงคลทอง
Publication of TH168784A publication Critical patent/TH168784A/th

Links

TH1601004991A 2015-04-10 TH168784A (enExample)

Publications (1)

Publication Number Publication Date
TH168784A true TH168784A (enExample) 2017-10-05

Family

ID=

Similar Documents

Publication Publication Date Title
CY1122804T1 (el) Μονοκλωνικα αντισωματα εναντι ανθρωπινου αντιγονου ωριμανσης β κυτταρων (βcμα)
SI3638698T1 (sl) Protitelesa proti-TMPRSS2 in delci, ki vežejo antigen
ECSP18095014A (es) Proteínas de unión biespecíficas que se unen a una proteína inmunomoduladora y a un antígeno tumoral
MX2018009581A (es) Inmunoglobulina con fabs en tandem y sus usos.
BR112019011186A2 (pt) conjugado de anticorpo radiomarcado, composto, e, métodos de imageamento e para tratamento de um tumor.
CU20170169A7 (es) Anticuerpos de factor xi
TW201613962A (en) Fabs-in-tandem immunoglobulin and uses thereof
BR112016014022A2 (pt) anticorpos anti-cd3, ácido nucleico isolado, vetor, célula hospedeira, método de produção do anticorpo anti-cd3, imunoconjugado, composição, uso do anticorpo anti-cd3, métodos de tratamento, métodos de intensificação da função imune e kit
CL2018000431A1 (es) Anticuerpos anti-bcma, moléculas de unión de antígeno específicas que vinculan bcma y cd3, y sus usos relacionados.
AU2018253589A1 (en) Antibodies, pharmaceutical compositions and uses thereof
CA2986942C (en) Anti-tau antibodies and methods of use
PE20180670A1 (es) Neoantigenos compartidos
HUE047922T2 (hu) Rák kezelésére, metasztatikus rákos sejtek elpusztítására és rák metasztázisának megelõzésére szolgáló, módszer és készítmény elõrehaladott glikációs végtermékek (AGE) elleni antitestek felhasználásával
BR112017002183A2 (pt) conjugado, composição farmacêutica, e, método para aumentar uma resposta imune em um mamífero
WO2018069871A3 (en) Anti-kras binding proteins
WO2017062496A3 (en) Anti-sas1b antibodies, associated methods of use, and compositions and methods for detecting and treating cancer
IL271427A (en) Compositions and methods for inducing humoral and cellular immunities against tumors and cancer
CA2991868C (en) PROTEIN 2 CONTAINING THE MOTILE SPERM DOMAIN AND CANCER
EP3455261A4 (en) ANTI-ROR2 ANTIBODIES, ANTIBODY FRAGMENTS, THEIR IMMUNOCONJUGATES, AND USES THEREOF
EA201792058A1 (ru) Виротерапия комбинацией антител
EA200900738A1 (ru) Слитые белки, содержащие антигены отторжения опухоли ny-eso-1 и lage-1
EP3672635A4 (en) Monoclonal antibodies against pathological alpha-synuclein, and methods using same
EA201792312A1 (ru) Конструкции на основе калихеамицина и способы их применения
IL285881A (en) Cells, compositions and methods for enhancing immune function
TH168784A (enExample)